Murray, Melissa E.

APOE genotype determines cell-type-specific pathological landscape of Alzheimer’s disease

Li, Z., Martens, Y. A., Ren, Y., Jin, Y., Sekiya, H., Doss, S. V., Kouri, N., Castanedes-Casey, M., Christensen, T. A., Miller Nevalainen, L. B., et al. (2025) · Neuron

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 39

18F-fluorodeoxyglucose positron emission tomography in dementia with Lewy bodies

Graff-Radford, J., Lesnick, T. G., Savica, R., Chen, Q., Ferman, T. J., Przybelski, S. A., Jones, D. T., Senjem, M. L., Gunter, J. L., Kremers, W. K., et al. (2020) · Brain Communications

Dementia and Cognitive Impairment ResearchParkinson's Disease Mechanisms and Treatments

Cited by 28

An FDG-PET-based machine learning framework to support neurologic decision-making in Alzheimer disease and related disorders

Barnard, L., Botha, H., Corriveau-Lecavalier, N., Graff-Radford, J., Dicks, E., Gogineni, V., Zhang, G., Burkett, B. J., Johnson, D. R., Huls, S. J., et al. (2025) · Neurology

Dementia and Cognitive Impairment ResearchArtificial Intelligence in Healthcare and Education

Cited by 25

Association of ABI3 and PLCG2 Missense Variants With Disease Risk and Neuropathology in Lewy Body Disease and Progressive Supranuclear Palsy

Strickland, S. L., Morel, H., Prusinski, C., Allen, M., Patel, T. A., Carrasquillo, M. M., Conway, O. J., Lincoln, S. J., Reddy, J. S., Nguyen, T., et al. (2020) · Acta Neuropathologica Communications

Parkinson's Disease Mechanisms and TreatmentsAlzheimer's disease research and treatments

Cited by 15

Integrative epigenomic landscape of Alzheimer’s Disease brains reveals oligodendrocyte molecular perturbations associated with tau

Oatman, S. R., Reddy, J. S., Atashgaran, A., Wang, X., Min, Y., Quicksall, Z., Vanelderen, F., Carrasquillo, M. M., Liu, C.-C., Yamazaki, Y., et al. (2026) · Nature Communications

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 6